Define atherosclerosis. Describe its risk factors, pathogenesis, morphology and complications.
Definition
Atherosclerosis is a disease of large and medium-sized arteries characterised by intimal lesions called atheromas (fibrofatty plaques) that protrude into the lumen, weaken the underlying media, and may rupture to cause catastrophic thrombosis.
| Term | Meaning |
|---|---|
| Arteriosclerosis | The general term — "hardening of the arteries" |
| ATHEROsclerosis | Intimal plaques in large and medium arteries; by far the most important |
| Monckeberg medial sclerosis | Calcification of the media of muscular arteries in the elderly; does not narrow the lumen and is usually of no clinical consequence |
| Arteriolosclerosis | Small arteries and arterioles; hyaline type in diabetes and benign hypertension, hyperplastic ("onion-skin") type in malignant hypertension |
Risk Factors
| Category | Factors |
|---|---|
| Non-modifiable | Age (the strongest single factor); male sex (women are protected until the menopause); family history and genetic factors, including familial hypercholesterolaemia |
| Modifiable — major | Hyperlipidaemia — raised LDL and low HDL; hypertension; smoking; diabetes mellitus |
| Minor and emerging | Obesity, physical inactivity, stress and "type A" personality, raised C-reactive protein, hyperhomocysteinaemia, lipoprotein(a), metabolic syndrome |
- The four major modifiable factors are multiplicative, not additive — a smoker with hypertension and diabetes has a risk far greater than the sum of the three
- South Asians develop coronary disease about a decade earlier and at lower body mass indices than Europeans, with a characteristic pattern of low HDL, high triglycerides and central obesity
Pathogenesis — the Response-to-injury Hypothesis
- 1. Endothelial injury or dysfunction — from haemodynamic stress, hyperlipidaemia, smoking, hypertension, toxins → 2.
- Increased permeability
- LDL enters the intima and is oxidised → 3.
- Monocytes adhere (through VCAM-1) and migrate into the intima → They become macrophages, take up oxidised LDL through scavenger receptors — which are not downregulated by cholesterol — and become foam cells → 4.
- Fatty streak forms — the earliest lesion, present even in children → 5.
- Smooth muscle cells migrate from the media to the intima, driven by PDGF, FGF and TGF-alpha → They proliferate and secrete collagen and matrix → 6.
- Fibrofatty plaque (atheroma) — a fibrous cap over a necrotic lipid core → 7.
- Complications — rupture, thrombosis, calcification, aneurysm
- Chronic inflammation drives the whole process; atherosclerosis is now understood as an inflammatory disease of the vessel wall, not simply lipid deposition
- The scavenger receptor is the key to foam cell formation — unlike the normal LDL receptor it is not suppressed by intracellular cholesterol, so the macrophage goes on ingesting lipid until it is engorged
Morphology
- Sites, in descending order of severity — lower abdominal aorta > coronary arteries > popliteal > internal carotid > circle of Willis
- Plaques form at points of turbulence — ostia, branch points and the posterior abdominal aorta, where laminar flow is disturbed
- Fatty streak — flat yellow intimal discolouration of lipid-laden macrophages; present in the aorta of nearly all children over 10; not all progress to plaques
| Component of the plaque | Contents |
|---|---|
| Fibrous cap | Smooth muscle cells, dense collagen, elastin, proteoglycans; determines stability |
| "Shoulder" region | Macrophages, T cells, smooth muscle cells; the site where rupture usually begins |
| Necrotic core | Lipid (chiefly cholesterol, seen as cholesterol clefts), foam cells, cell debris, fibrin, calcium, neovascular channels |
CLINICAL PEARL
The plaques that kill are not the ones that narrow the lumen most. Most infarcts arise from a plaque causing less than 50% stenosis that ruptures. A vulnerable plaque has a thin cap, a large lipid core and many inflammatory cells; a stable one has a thick fibrous cap and little lipid. This is why statins save lives largely by stabilising plaques, not by shrinking them, and why an angiogram cannot predict where the next infarct will occur.
Complications
| Complication | Consequence |
|---|---|
| Rupture, ulceration or erosion | Exposes thrombogenic material → acute thrombosis → myocardial infarction, stroke, gangrene — the major mechanism of death |
| Haemorrhage into the plaque | From fragile neovessels; expands the plaque abruptly |
| Atheroembolism | Cholesterol crystal emboli → blue toe syndrome, renal impairment |
| Progressive stenosis | "Critical stenosis" at about 70% — ischaemia on exertion: angina, intermittent claudication, mesenteric angina |
| Aneurysm formation | Pressure atrophy and weakening of the underlying media — abdominal aortic aneurysm |
| Calcification | Rigidity; visible on radiographs |
Clinical Consequences BY Territory
| Artery involved | Syndrome | Presentation |
|---|---|---|
| Coronary | Ischaemic heart disease | Stable angina (fixed stenosis), unstable angina and myocardial infarction (plaque rupture), sudden cardiac death, chronic ischaemic cardiomyopathy |
| Cerebral and carotid | Cerebrovascular disease | Transient ischaemic attack, ischaemic stroke, vascular dementia |
| Lower limb | Peripheral arterial disease | Intermittent claudication, rest pain, ulceration, gangrene |
| Mesenteric | Chronic mesenteric ischaemia | Post-prandial abdominal pain ("mesenteric angina"), weight loss, food fear; acute occlusion gives bowel infarction |
| Renal | Renovascular disease | Secondary hypertension, ischaemic nephropathy |
| Abdominal aorta | Aneurysm | Asymptomatic pulsatile mass; rupture |
- The consequence depends on whether the plaque narrows slowly or ruptures suddenly — slow narrowing gives exertional symptoms and allows collaterals to form; rupture gives an acute event with no warning
Applied Aspects
- Prevention is far more effective than treatment — stopping smoking, controlling blood pressure and diabetes, exercise, and diet
- Statins lower LDL and stabilise plaques, and reduce events more than the cholesterol reduction alone would predict, because of their anti-inflammatory effect
- Familial hypercholesterolaemia — an LDL receptor defect causing tendon xanthomas, corneal arcus and myocardial infarction in early adult life; requires family screening
- Coronary artery disease is rising steeply in India, presenting a decade earlier than in the West and increasingly in rural populations
- Atherosclerosis is a systemic disease — a patient with peripheral vascular disease almost certainly has coronary disease too, and should be assessed for it
- The process begins in childhood and progresses silently for decades, which is the argument for lifelong risk factor control rather than treatment at presentation
- Regression is possible — intensive lipid lowering reduces plaque volume modestly, but the greater benefit is in stabilising the cap
- Diabetes confers a risk equivalent to existing coronary disease, and diabetic patients are treated as secondary prevention from the outset
- C-reactive protein predicts events independently of cholesterol, consistent with the inflammatory model, though its use in routine practice is debated
- Coronary calcium scoring quantifies plaque burden non-invasively and refines risk in intermediate-risk patients
- A normal angiogram does not mean normal arteries — plaque expands outward before it narrows the lumen (Glagov remodelling), so early disease is angiographically invisible
All questions in Cardiovascular Pathology
- Q1Define atherosclerosis. Describe its risk factors, pathogenesis, morphology and complications. ★
- Q2Describe the pathogenesis, morphological evolution, laboratory diagnosis and complications of myocardial infarction. ★
- Q3Describe the pathogenesis, Jones criteria and morphology of rheumatic fever. Add a note on chronic rheumatic heart disease. ★
- Q4Describe the aetiology, pathogenesis, morphology and clinical features of infective endocarditis. ★
- Q5Classify vasculitis. Describe the important large, medium and small vessel vasculitides. ★
- SN1Define aneurysm. Classify aneurysms and describe abdominal aortic aneurysm and aortic dissection. ★
- SN2Classify cardiomyopathies and describe their features. ★
- SN3Describe hypertension with its types and the pathology of hypertensive heart disease. ★
- SN4Classify pericarditis. Describe cardiac tamponade and constrictive pericarditis. ★
- SN5Classify congenital heart disease. Describe the tetralogy of Fallot and Eisenmenger syndrome. ★
- SN6Describe the complications of myocardial infarction with their timing. ★
- SN7Describe myocarditis with its causes, morphology and clinical features.